Development and preliminary validation of a Chinese patient-reported Japanese Orthopaedic Association score for cervical spondylotic myelopathy
Spine Research · 20.11.2026
DOI: 10.1097/br9.0000000000000052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spine Research, online erschienen am 20.11.2026. Verfasst von Xinhang Li und 6 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Japanese Orthopaedic Association (JOA) score is widely used to assess neurological function in cervical spondylotic myelopathy (CSM), but its physician-assessed format may be influenced by rater-related variation. We developed a Chinese patient-reported JOA score (P-JOA) based on the 17-2 point JOA system and evaluated its preliminary measurement properties.
Methods
This prospective observational cohort included 120 patients with CSM who completed the P-JOA twice before surgery. Test–retest analyses were restricted to 92 participants whose two P-JOA administrations were separated by no more than 14 days. A blinded physician independently completed the conventional JOA assessment at the second P-JOA administration. Participants also completed the neck disability index (NDI) and the 36-Item Short Form Health Survey (SF-36). Reliability, agreement, and construct validity were evaluated using paired tests, absolute-agreement intraclass correlation coefficients (ICCs), Bland–Altman analysis, and Spearman rank correlations.
Results
The mean age was 54.6 ± 10.1 years. Among the 92 participants retested within 14 days, the first and second P-JOA scores were 13.60 ± 2.63 and 13.54 ± 2.72, respectively ( p = 0.707), and the total-score ICC(A,1) was 0.809 (95% confidence interval [CI], 0.724–0.869). Agreement between the second P-JOA and physician-assessed JOA was high in all 120 participants (absolute-agreement ICC = 0.932; 95% CI, 0.904–0.952). The P-JOA 2 total score correlated with SF-36 physical functioning (Spearman ρ = 0.485) but not with NDI (Spearman ρ = −0.051).
Conclusions
The Chinese P-JOA showed good short-interval test–retest reliability and high agreement with physician-assessed JOA scores. It may be useful as a complementary patient-reported assessment, but further multicenter and hypothesis-driven validation is required.
Zitieren
APA
Li, X., Li, Z., Pan, S., Zhao, Y., Chen, X., Sun, Y., & Zhou, F. (2026). Development and preliminary validation of a Chinese patient-reported Japanese Orthopaedic Association score for cervical spondylotic myelopathy. Spine Research. https://doi.org/10.1097/br9.0000000000000052
Vancouver
Li X, Li Z, Pan S, Zhao Y, Chen X, Sun Y, et al. Development and preliminary validation of a Chinese patient-reported Japanese Orthopaedic Association score for cervical spondylotic myelopathy. Spine Research. 2026. doi:10.1097/br9.0000000000000052
BibTeX
@article{Li2026,
author = {Li, Xinhang and Li, Zhenxu and Pan, Shengfa and Zhao, Yanbin and Chen, Xin and Sun, Yu and Zhou, Feifei},
title = {Development and preliminary validation of a Chinese patient-reported Japanese Orthopaedic Association score for cervical spondylotic myelopathy},
journal = {Spine Research},
year = {2026},
doi = {10.1097/br9.0000000000000052}
}
EUVIMED